The LDN Shop
Visit our e-commerce website for Conferences, Webinars, Medical Membership, eBooks etc
LDN Social Media
Get connected with us on social networks
Coronavirus
What COVID-19 Teaches Us About Rare Diseases
Pain News Network
27 February 2021
https://www.painnewsnetwork.org/stories/2021/2/26/what-covid-19-teaches-us-about-rare-diseases
SINK COVID-19 study: Can common drugs offer 2-step approach to combat deadly virus?
Beaumont News Releases
04 May 2020
https://www.beaumont.org/health-wellness/press-releases/sink-covid-19-study-can-common-drugs-offer-2-step-approach-to-combat-deadly-virus
Impact of Colchicine and Low-dose Naltrexone on COVID-19 (COLTREXONE)
HealthPartners institute
16 February 2021
https://clinicaltrials.gov/ct2/show/NCT04756128
Scientists Think They've Figured Out What's Triggering Brain Fog in COVID-19 Patients
MSN News Science Alert
11 February 2021
https://www.msn.com/en-us/news/technology/scientists-think-theyve-figured-out-whats-triggering-brain-fog-in-covid-19-patients/ar-BB1dBTTF?li=BBnbfcL
Inflammatory Leptomeningeal Cytokines Mediate COVID-19 Neurologic Symptoms in Cancer Patients
Cancer Cell
16 January 2021
https://www.cell.com/cancer-cell/fulltext/S1535-6108(21)00051-9
Halberd Corp. Develops Medication to Boost Immune System Against SARS-CoV-2 (Covid-19)
LancasterOnline
14 Jan 2021
https://lancasteronline.com/news/health/halberd-corp-develops-medication-to-boost-immune-system-against-sars-cov-2-covid-19/article_78231771-5ffe-5bd0-87ec-a01a9d114ae9.html
Pilot Study Into the Use of Metformin and LDN for Patients With COVID-19 (Study)
Pilot study into low dose naltrexone (LDN) and NAD+ for treatment of patients with post-COVID-19 syndrome (Study)
https://clinicaltrials.gov/ct2/show/NCT04604704
This study will assess the use of low dose naltrexone (LDN) and NAD+ for the treatment of patients with post-COVID-19 syndrome (long-COVID-19).
Naltrexone a potential therapeutic candidate for COVID-19 (Abstract)
J Biomol Struct Dyn
15 Sept 2020
https://pubmed.ncbi.nlm.nih.gov/32930058/